Acadian Asset Management LLC Poseida Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 831,041 shares of PSTX stock, worth $2.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
831,041
Previous 399,839
107.84%
Holding current value
$2.67 Million
Previous $1.17 Million
103.86%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PSTX
# of Institutions
97Shares Held
38.4MCall Options Held
377KPut Options Held
22.2K-
Pentwater Capital Management LP Naples, FL5.98MShares$19.2 Million0.18% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$15.7 Million0.0% of portfolio
-
Silverarc Capital Management, LLC3.69MShares$11.8 Million2.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$11.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$7.04 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $275M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...